Skip to main content
. 2021 Mar 16;21(5):491. doi: 10.3892/etm.2021.9922

Figure 4.

Figure 4

SUMO1P3 acts as a tumour promoter by regulating the expression levels of β-catenin, cyclin-D1, N-cadherin and E-cadherin. (A) Western blot analysis was performed to detect relative protein expression levels of N-cadherin, E-cadherin, β-catenin and cyclin-D1 in U251 and LN229 siRNA-transfected glioma cells. (B-E) Statistical analysis for the western blotting results of (B) β-catenin, (C) cyclin-D1, (D) N-cadherin and (E) E-cadherin. Data are presented as the mean ± standard error of the mean. *P<0.05; **P<0.01. SUMO1P3, small ubiquitin-like modifier 1 pseudogene 3; siRNA, small interfering RNA; NC, negative control.